Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders [Yahoo! Finance]
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share
Daxor Scales Outpatient Presence; Launches BVA Diagnostic Program in Tennessee
Daxor (NASDAQ:DXR) is now covered by analysts at Lake Street Capital. They set a "buy" rating on the stock.